DSCSA 2024 Ten Count: Number 6-Exception Handling Building Resilient Processes

Ten Count Consulting reflects on 2024 with our list of top DSCSA moments and stories from 2024.

DSCSA Exception Handling: Building Resilient Processes for 2025 and Beyond

The FDA's stabilization period aimed to give trading partners the opportunity to build and validate interoperable systems, manage products and data effectively, and ensure the continuous availability of products for patients. Throughout 2024, distributors significantly increased their efforts to receive serialized products and reconcile product data. As data utilization expanded downstream, differences between physical products and digital records became more evident. This post explores exception-handling practices, informed by the latest guidelines, pilot studies, and industry discussions.

Understanding DSCSA Exceptions

Exceptions occur when there is a mismatch between physical products and their associated digital transaction or initiating master data. Common exception categories include:

As highlighted in the previous post on the DSCSA Stabilization Period Checkpoint PDG-FDA Joint Public Meeting, achieving 100% data accuracy is unrealistic. Given the enormous volume of unit-level transactions, errors are inevitable. Therefore, the focus must shift to developing well-controlled, risk-based processes that effectively manage these discrepancies and prevent their recurrence.

Key Principles for Exception Management

  1. Prioritize Legitimate Product Movement: Minimize disruptions to avoid product shortages.
  2. Implement Structured, Risk-Based Processes: Relying on reactive, ad-hoc solutions is unsustainable. A formal system involving cross-functional teams and clearly defined workflows is essential.
  3. Thorough Documentation: Maintain comprehensive records of exceptions and resolutions to meet regulatory requirements.
  4. Foster Effective Collaboration: Timely communication between trading partners is critical for resolving issues.

Links to Industry Guidelines, Pilot Studies, and Work Groups on Exceptions

Exception handling requires a solid alignment with trading partners and the industry on how each scenario of exceptions should be handled. While exceptions often require real-time analysis to understand the root causes and resolutions, most exceptions are experienced across the industry and can benefit from good planning and continuous improvement. These are some of the more common publications that outline industry work done to date:

HDA Publications- Exception Handling for DSCSA:

Partnership for DSCSA Governance (PDG), Healthcare Distribution Alliance (HDA), & GS1 US Exception Handling Workshop Report

Partnership for DSCSA Governance (PDG) Root Causes Document

Developing Robust Exception Handling Systems

As industry-independent exploration in late 2024 shifted towards exploring building sustainable exception-handling processes, key considerations emerged:

Identify Input Sources and Engage Stakeholders:

Streamline Initial Intake Processes:

Establish Clear Resolution and Escalation Paths:

Implement Preventive Measures:

Create Feedback Loops:

This is not an exhaustive list but highlights critical steps and questions for strengthening exception management as we move into 2025.

Conclusion

Exception handling is essential for DSCSA compliance, demanding vigilance, collaboration, and adaptability to evolving standards. By engaging in industry dialogue, adopting best practices, and leveraging available tools, trading partners can safeguard the efficient and secure movement of products throughout the supply chain.

Ten Count Consulting is here to guide your organization in developing and implementing effective DSCSA exception-handling strategies to ensure compliance and supply chain integrity. In addition to developing robust exception-handling systems and processes, organizations need to ensure they have the proper resources to execute them. Depending on the volume of transactions being managed, resources can be stretched thin and often be overwhelmed by the complexity of DSCSA exceptions. Without the proper context and experience, exception handling can be a full-time job (or more). Reach out to us if you would like an independent perspective on the tools and services that are available in these areas.

The List Revealed So Far:

Number 10: Decommissioning: Can the End of Commerce Serial Number Decommissioning Play a Role in Preventing and Detecting Counterfeit Drugs?

Number 9: FDA 483s Issued for DSCSA Requirements

Number 8: Two-Year Exemption for Small Dispensers

Number 7: DSCSA Stabilization Period Checkpoint PDG-FDA Joint Public Meeting

Stay tuned to our blog over the coming days as we share the remaining 5 highlights of 2024!

Number 5

Number 4

Number 3

Number 2

Number 1

Ready to grow your confidence in DSCSA compliance?